Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3486574 | 0.83 | KMT2A (0.38) | ENTPD2 | |
| SCHEMBL3486581 | 0.76 | P2RY12 (0.32) | P2RY12 | |
| SCHEMBL9069548 | 0.76 | P2RY12 (0.36) | P2RY12 | |
| SCHEMBL6223334 | 0.73 | P2RY12 (0.34) | P2RY12 | |
| SCHEMBL10458515 | 0.72 | LMNA (0.43) | — | |
| SCHEMBL9069521 | 0.72 | P2RY2 (0.35) | ENTPD2P2RY12 | |
| SCHEMBL11482636 | 0.68 | SLC28A1 (0.40) | ENTPD2 | |
| SCHEMBL7677678 | 0.66 | SLC28A1 (0.40) | ENTPD2 | |
| SCHEMBL11483176 | 0.66 | SLC28A1 (0.40) | ENTPD2 | |
| SCHEMBL25433501 | 0.66 | SLC28A1 (0.58) | ENTPD2P2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073640-A1 | Novel compositions for the delivery of negatively charged molecules | RIBOZYME PHARMACEUTICALS, INC. | 2003-04-17 | — | — | US | claimed |
| US-10131590-B2 | Ethylene tetramerization catalyst system and method for preparing 1-octene using the same | SK INNOVATION CO., LTD. (KR) | 2018-11-20 | — | — | US | disclosed |
| US-20180016206-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEM AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | SK INNOVATION CO., LTD. (KR) | 2018-01-18 | — | — | US | disclosed |
| US-9802874-B2 | Ethylene tetramerization catalyst systems and method for preparing 1-octene using the same | SK INNOVATION CO., LTD. (KR) | 2017-10-31 | — | — | US | disclosed |
| US-20140081064-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEMS AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | SK INNOVATION CO., LTD. & SK GLOBAL CHEMICAL CO. LTD. (KR) | 2014-03-20 | — | — | US | disclosed |
| US-8609924-B2 | Ethylene tetramerization catalyst systems and method for preparing 1-octene using the same | SK INNOVATION CO., LTD. (KR) | 2013-12-17 | — | — | US | disclosed |
| US-20100137669-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEMS AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | SK INNOVATION CO., LTD. (KR) | 2010-06-03 | — | — | US | disclosed |
| US-20100036115-A1 | Novel Compositions for the Delivery of Negatively Charged Molecules | SIRNA THERAPEUTICS, INC. (US) | 2010-02-11 | — | — | US | disclosed |
| US-7553830-B2 | Compositions for the delivery of negatively charged molecules | SIRNA THERAPEUTICS, INC. (US) | 2009-06-30 | — | — | US | disclosed |
| EP-1724254-A2 | Novel compositions for the delivery of negatively charged molecules | Sirna Therapeutics, Inc. (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20050234232-A1 | Novel compositions for the delivery of negatively charged molecules | SIRNA THERAPEUTICS, INC. | 2005-10-20 | — | — | US | disclosed |
| US-20030073640-A1 | Novel compositions for the delivery of negatively charged molecules | RIBOZYME PHARMACEUTICALS, INC. | 2003-04-17 | — | — | US | disclosed |
| US-6395713-B1 | CATIONIC LIPIDCATIONIC LIPID | RIBOZYME PHARMACEUTICALS, INC. | 2002-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137669-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEMS AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | TCP1, CTR9, CTRC | ENTPD2 2555/4885P2RY12 2304/4885 |
| US-20100036115-A1 | Novel Compositions for the Delivery of Negatively Charged Molecules | PHAX, TARBP1, SNRPE | ENTPD2 553/4885P2RY12 3713/4885 |
| US-10131590-B2 | Ethylene tetramerization catalyst system and method for preparing 1-octene using the same | TCP1, CTRC, CTR9 | ENTPD2 2574/4885P2RY12 2168/4885 |
| US-20180016206-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEM AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | TCP1, CTRC, CTR9 | ENTPD2 2574/4885P2RY12 2168/4885 |
| US-20050234232-A1 | Novel compositions for the delivery of negatively charged molecules | PHAX, TARBP1, SNRPE | ENTPD2 553/4885P2RY12 3713/4885 |
| US-20140081064-A1 | ETHYLENE TETRAMERIZATION CATALYST SYSTEMS AND METHOD FOR PREPARING 1-OCTENE USING THE SAME | TCP1, CTR9, CTRC | ENTPD2 2555/4885P2RY12 2304/4885 |
| US-20030073640-A1 | Novel compositions for the delivery of negatively charged molecules | PHAX, TARBP1, SNRPE | ENTPD2 553/4885P2RY12 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.